BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 32395964)

  • 21. The unique characteristics of COVID-19 coagulopathy.
    Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
    Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulopathy in COVID-19.
    Iba T; Levy JH; Levi M; Thachil J
    J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulopathy of Coronavirus Disease 2019.
    Iba T; Levy JH; Levi M; Connors JM; Thachil J
    Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-associated coagulopathy: An exploration of mechanisms.
    Colling ME; Kanthi Y
    Vasc Med; 2020 Oct; 25(5):471-478. PubMed ID: 32558620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19-associated coagulopathy.
    Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
    Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response.
    Jayarangaiah A; Kariyanna PT; Chen X; Jayarangaiah A; Kumar A
    Clin Appl Thromb Hemost; 2020; 26():1076029620943293. PubMed ID: 32735131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
    Langer F; Kluge S; Klamroth R; Oldenburg J
    Hamostaseologie; 2020 Aug; 40(3):264-269. PubMed ID: 32498097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.
    Wright FL; Vogler TO; Moore EE; Moore HB; Wohlauer MV; Urban S; Nydam TL; Moore PK; McIntyre RC
    J Am Coll Surg; 2020 Aug; 231(2):193-203.e1. PubMed ID: 32422349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the COVID-19 coagulopathy spectrum.
    Thachil J; Agarwal S
    Anaesthesia; 2020 Nov; 75(11):1432-1436. PubMed ID: 32437586
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombosis and Coagulopathy in COVID-19.
    Gómez-Mesa JE; Galindo-Coral S; Montes MC; Muñoz Martin AJ
    Curr Probl Cardiol; 2021 Mar; 46(3):100742. PubMed ID: 33243440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19.
    Quitadamo PA; Comegna L; Cristalli P
    Front Public Health; 2020; 8():589736. PubMed ID: 33738273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Patients with SARS-CoV-2 Infection: Clinical Characteristics in the United States from a Large Global Health Research Network.
    Desai A; Mills A; Delozier S; Cabrera Aviles C; Edwards A; Dirajlal-Fargo S; McComsey G
    Cureus; 2020 Sep; 12(9):e10413. PubMed ID: 33062530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dealing with COVID-19-associated coagulopathy].
    Klok FA; den Exter PL; Huisman MV; Eikenboom J
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coagulopathy and COVID-19. Recommendations for a changing reality].
    Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
    Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
    Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
    J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
    Amgalan A; Othman M
    Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.